(267 days)
Not Found
No
The device description and performance studies focus on the physical properties and biological interactions of a traditional menstrual tampon, with no mention of AI or ML technologies.
No
The device is intended for absorption of menstrual or other vaginal discharge, which is a hygienic function and not a therapeutic one. It does not treat or prevent any disease or condition.
No
The device description and intended use clearly state that it is for absorption of menstrual or other vaginal discharge, not for diagnosing any condition.
No
The device description clearly outlines physical components like absorbent pledgets, removal strings, and cardboard applicators, indicating it is a physical medical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the absorption of menstrual or other vaginal discharge. This is a physical function, not a diagnostic one. IVDs are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.
- Device Description: The description details the physical components and materials of a tampon, which is a medical device for absorption, not for analyzing biological samples.
- Performance Studies: The performance studies focus on the physical and biological safety of the tampon (biocompatibility, microbiology, performance testing like absorbency and string strength). These are relevant to a medical device for absorption and insertion, not for diagnostic accuracy.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples, detecting biomarkers, or providing diagnostic information.
Therefore, the Unscented Tampon, as described, is a medical device intended for absorption, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Unscented Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.
Product codes
HEB
Device Description
The Unscented Tampons are traditional unscented menstrual tampons. Except for the raw materials, they share the same design. The Unscented Tampons are provided with a cardboard applicator tampon. Each device consists of a tampon, including an absorbent 100% organic cotton or 100% viscose pledget , a 100% organic cotton or polyester and cotton removal string ("withdrawal cord"), and a cardboard applicator . The tampon is of the traditional cylindrical, bullet-like shape. The applicator has a smooth, rounded tip to ease insertion.
The Unscented Tampons are provided in 4 absorbencies: light (less than or equal to 6g), regular (69g), super (912g) and super plus (12~15g). Each device is individually wrapped. It is provided non-sterile and for single use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vagina
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing was conducted to verify that the subject devices meet all design and performance specifications similarly to the predicate device.
Biocompatibility studies were performed on the organic cotton tampon and the viscose tampon per ISO 10993-5:2009 (In vitro cytotoxicity test), ISO 10993-10:2021 (Skin sensitization test), ISO 10993-23:2021 (Vaginal irritation test), and ISO 10993-11:2017 (Acute systemic toxicity test). The results demonstrated that the subject device is non-cytotoxic, non-sensitizing, and non-systemically toxic.
Microbiology testing was conducted on the organic cotton tampon and the viscose tampon. The test results showed that the subject devices do not: enhance the growth of Staphylococcus aureus; increase the production of Toxic Shock Syndrome Toxin-1 (TSST-1); and do not alter the growth of normal vaginal microflora.
Performance characteristics assessed on the organic cotton tampon and the viscose tampon include: Dimensions, String strength, Absorbency per Syngyna Testing (21 CFR 801.430), Applicator expulsion force, Appearance, Applicator and tampon integrity, Fiber shedding, and Chemical residues.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.5470 Unscented menstrual tampon.
(a)
Identification. An unscented menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. This generic type of device does not include menstrual tampons treated with scent (i.e., fragrance materials) or those with added antimicrobial agents or other drugs.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
January 10, 2025
Shandong Intco Hygiene Products Co., Ltd. Max Li 0A Workshop C3, No. 29, Zhangliu Road, Fangzhen Town Zhangdian DistrictZibo. Shandong 255000 China
Re: K241064
Trade/Device Name: Unscented Tampon Regulation Number: 21 CFR§ 884.5470 Regulation Name: Unscented Menstrual Tampon Regulatory Class: II Product Code: HEB Dated: December 13, 2024 Received: December 13, 2024
Dear Max Li:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
2
3
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Reginald K. Avery -S
for Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below.
Submission Number (if known)
Device Name
Unscented Tampon
Indications for Use (Describe)
The Unscented Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image shows the logo for INTCO Medical. The logo features the word "INTCO" in a bold, sans-serif font, with the letters in blue. Above the word "INTCO" is a stylized graphic resembling a flower or sunburst, also in blue. Below the word "INTCO" are Chinese characters, also in blue, which likely represent the company's name in Chinese.
510(k) Summary
(As requirement by 21 CFR 807.92)
Date prepared: January 9, 2025
A. Applicant:
Name: SHANDONG INTCO HYGIENE PRODUCTS CO., LTD. Address: Workshop C3, No. 29, Zhangliu Road, Fangzhen Town Zhangdian District Zibo,Shandong Province,China Contact: Ms. Jia shuangshuang Title: QA Tel: +86-533-6298778 Email: jiashuangshuang@intco.com
Submission Correspondent: Primary contact: Maxli SHANDONG INTCO HYGIENE PRODUCTS CO., LTD. Workshop C3, No. 29, Zhangliu Road, Fangzhen Town Zhangdian District Zibo, Shandong Province, China Tel: +86-533-6298778 Email: maxli@intco.com Secondary contact: Jia shuangshuang Workshop C3, No. 29, Zhangliu Road, Fangzhen Town Zhangdian District Zibo, Shandong Province, China Tel: +86-533-6298778 Email: jiashuangshuang@intco.com
B. Device:
Trade Name: Unscented Tampon Common Name: Unscented Menstrual Tampon
Regulatory Information Classification Name: Tampon, Menstrual, Unscented Classification: Class II Product code: HEB Regulation Number: 21 CFR 884.5470 Review Panel: Obstetrics/Gynecology
C. Predicate device:
K231341
Organic cotton tampon, Viscose tampon Zhejiang Tianqing Manufacturing Technology Group Co., Ltd. The predicate device has not been subject to a design-related recall.
5
Image /page/5/Picture/0 description: The image contains the logo for INTCO Medical. The logo features the word "INTCO" in a bold, sans-serif font, with the letters in blue. Above the word "INTCO" is a stylized graphic of a blue flower or sunburst with multiple petals or rays emanating from a central point. Below the word "INTCO" are the Chinese characters "英科医疗" which translates to "INTCO Medical".
D. Indications for use of the device:
The Unscented Tampon is intended for insertion into the absorption of menstrual or other vaginal discharge.
E. Device Description:
The Unscented Tampons are traditional unscented menstrual tampons. Except for the raw materials, they share the same design. The Unscented Tampons are provided with a cardboard applicator tampon. Each device consists of a tampon, including an absorbent 100% organic cotton or 100% viscose pledget , a 100% organic cotton or polyester and cotton removal string ("withdrawal cord"), and a cardboard applicator . The tampon is of the traditional cylindrical, bullet-like shape. The applicator has a smooth, rounded tip to ease insertion.
The Unscented Tampons are provided in 4 absorbencies: light (≤6g), regular (69g), super (912g) and super plus (12~15g). Each device is individually wrapped. It is provided non-sterile and for single use only.
F. Summary of Technological Characteristics
The Unscented Tampons are compared with the predicate device in terms of intended use, design, material, specifications, and performance.
The following table shows similarities and differences of use, design, and material between the proposed device and the predicate device.
| Device | Proposed Device | Predicate Device | Result |
|---|---|---|---|
| 510K # | -- | K231341 | -- |
| Manufacturer | SHANDONG INTCO HYGIENE | ||
| PRODUCTS CO., LTD. | Zhejiang Tianqing Manufacturing | ||
| Technology Group Co., Ltd. | -- | ||
| Product Name | Unscented Tampon | Organic cotton tampon / Viscose tampon | -- |
| Product Code | HEB | HEB | Same |
| Regulation | |||
| Number | 21 CFR 884.5470 | 21 CFR 884.5470 | Same |
| Classification | Class II | Class II | Same |
| Indications for use | The Unscented Tampon is intended for | ||
| insertion into the vagina for the | |||
| absorption of menstrual or other vaginal | |||
| discharge. | The tampon is intended for insertion | ||
| into the vagina for the absorption of | |||
| menstrual or other vaginal discharge. | Same | ||
| Single use | Yes | Yes | Same |
| Sterility | Non-Sterile | Non-Sterile | Same |
| Design feature | Tampon with cylindrical shape and | ||
| bullet-like tip.Applicator with smooth, | |||
| rounded tip. | Tampon with cylindrical shape and | ||
| bullet-like tip.Applicator with smooth, | |||
| rounded tip. | Same | ||
| Absorbency | Light: $\leq$ 6g | ||
| Regular: 6~9g | |||
| Super: 9~12g | |||
| Super plus: 12~15g | Light: $\leq$ 6g | ||
| Regular: 6~9g | |||
| Super: 9~12g | |||
| Super plus: 12~15g | Same |
Table 1 General Comparison of Proposed and Predicate Devices
6
Image /page/6/Picture/0 description: The image contains the logo for INTCO Medical. The logo features the word "INTCO" in a bold, sans-serif font, with the letters arranged horizontally. Below the word "INTCO" are two Chinese characters, followed by the word "Medical". Above the word "INTCO" is a stylized graphic consisting of several blue, petal-like shapes arranged in a circular pattern around a central blue dot. The overall impression is that of a modern and professional medical company.
| Product dimensions | ||||||
|---|---|---|---|---|---|---|
| Applicator tampon | ||||||
| Light | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45 - 50 mm$ | |||||
| $12.2 - 13.7 mm$ | ||||||
| $115 -175 mm$ | ||||||
| $120 - 125 mm$ | ||||||
| $13.8 - 14.2 mm$ | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $43~49 mm$ | |||||
| $9.5~12.5 mm$ | ||||||
| $120~160 mm$ | ||||||
| $130.1 mm$ | ||||||
| $15.2 mm$ | different | |||||
| Regular | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45 - 50 mm$ | |||||
| $12.2 - 13.7 mm$ | ||||||
| $115 -175 mm$ | ||||||
| $120 - 125 mm$ | ||||||
| $13.8 - 14.2 mm$ | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $44~50 mm$ | |||||
| $10.5~13.5 mm$ | ||||||
| $120~160 mm$ | ||||||
| $130.1 mm$ | ||||||
| $15.2 mm$ | different | |||||
| Super | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45 - 50 mm$ | |||||
| $14.2 - 15.7 mm$ | ||||||
| $115 -175 mm$ | ||||||
| $120 - 125 mm$ | ||||||
| $15.8 - 16.2 mm$ | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45~51 mm$ | |||||
| $11.5~14.5 mm$ | ||||||
| $120~160 mm$ | ||||||
| $131.0 mm$ | ||||||
| $16.7 mm$ | different | |||||
| Super plus | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45 - 50 mm$ | |||||
| $14.2 - 15.7 mm$ | ||||||
| $115 -175 mm$ | ||||||
| $120 - 125 mm$ | ||||||
| $15.8 - 16.2 mm$ | Pledget length | |||||
| Pledget diameter | ||||||
| Removal string length | ||||||
| Applicator length | ||||||
| Applicator diameter | $45~51 mm$ | |||||
| $12.5~15.5 mm$ | ||||||
| $120~160 mm$ | ||||||
| $131.0 mm$ | ||||||
| $16.7 mm$ | different | |||||
| Component | ||||||
| Materials | Pledget | 100% Organic Cotton / 100% | ||||
| Viscose | Pledget | 100% Organic Cotton / 100% | ||||
| Viscose | different | |||||
| Overwrap | Polyethylene and | |||||
| Polyethylene terephthalate | Overwrap | Polyethylene and | ||||
| Polyethylene terephthalate | ||||||
| Removal | ||||||
| string | 100% Organic Cotton / | |||||
| Polyester And Cotton | Removal | |||||
| string | 100% Organic Cotton / | |||||
| Polyester And Cotton | ||||||
| Applicator | Cardboard | Applicator | Polyethylene and | |||
| Polypropylene | ||||||
| Additives | ||||||
| and | ||||||
| Finishing | ||||||
| Agents | removal | |||||
| string | Paraffin-based resin | Repellan T | different | |||
| pledget | Polyoxyethylene stearate | Fiber finishes |
Analysis: The subject devices have the same indication for use as the predicate device; the subject device has the same intended use as the predicate device. The differences in technological characteristics between the subject and predicate devices, outlined in Table 1, do not raise different questions for safety and effectiveness.
G. Summary of Non-Clinical Testing
7
Image /page/7/Picture/0 description: The image shows the logo for INTCO Medical. The logo features the company name in blue, with a stylized graphic above it that resembles a flower or sunburst, also in blue. Below the company name, there are Chinese characters, also in blue, which likely represent the company's name or a related phrase in Chinese.
Non-clinical testing was conducted to verify that the subject devices meet all design and performance specifications similarly to the predicate device. The following tests were conducted.
> Biocompatibility
Biocompatibility studies were performed on the organic cotton tampon and the viscose tampon in accordance with the FDA guidance document " Guidance for Industry and Food and Drug Administration Staff - Use of International Standard ISO 10993-1, 'Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process' issued on September 4, 2020 as follows:
- In vitro cytotoxicity test per ISO 10993-5:2009
- Skin sensitization test per ISO 10993-10:2021
- · Vaginal irritation test per ISO 10993-23:2021
- · Acute systemic toxicity test per ISO 10993-11:2017(tampon only)
All the above tests were performed on the applicator, except acute systemic toxicity. The results demonstrated that the subject device is non-cytotoxic, non-sensitizing, and non-systemically toxic.
A Microbiology Testing
Per the FDA guidance document " Guidance for Industry and FDA Staff - Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s)" issued on July 27, 2005, the following microbiology testing was conducted on the highest absorbency of the finished form of the subject devices (i.e., the organic cotton tampon and the viscose tampon), and the test results showed that the subject devices do not:
- enhance the growth of Staphylococcus aureus;
- increase the production of Toxic Shock Syndrome Toxin-1 (TSST-1); and do not
- alter the growth of normal vaginal microflora.
A Performance Testing
The following performance characteristics were assessed on the organic cotton tampon and the viscose tampon in accordance with the FDA guidance document "Guidance for Industry and FDA Staff - Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s)" issued on July 27, 2005.
- Dimensions
- String strength
- · Absorbency per Syngyna Testing (21 CFR 801.430)
- Applicator expulsion force
- · Appearance
- · Applicator and tampon integrity
- · Fiber shedding
- · Chemical residues
H. Clinical Test Conclusion
No clinical study is included in this submission.
l. Conclusion
The conclusion drawn from the nonclinical tests demonstrates that the subject device in this 510(K) submission, the Unscented Tampons are as safe, as effective, and performs as well as or better than the legally marketed predicate device cleared under K231341.